325 related articles for article (PubMed ID: 17638705)
1. Peroxisomal-mitochondrial oxidation in a rodent model of obesity-associated insulin resistance.
Noland RC; Woodlief TL; Whitfield BR; Manning SM; Evans JR; Dudek RW; Lust RM; Cortright RN
Am J Physiol Endocrinol Metab; 2007 Oct; 293(4):E986-E1001. PubMed ID: 17638705
[TBL] [Abstract][Full Text] [Related]
2. Excess lipid availability increases mitochondrial fatty acid oxidative capacity in muscle: evidence against a role for reduced fatty acid oxidation in lipid-induced insulin resistance in rodents.
Turner N; Bruce CR; Beale SM; Hoehn KL; So T; Rolph MS; Cooney GJ
Diabetes; 2007 Aug; 56(8):2085-92. PubMed ID: 17519422
[TBL] [Abstract][Full Text] [Related]
3. Increased malonyl-CoA levels in muscle from obese and type 2 diabetic subjects lead to decreased fatty acid oxidation and increased lipogenesis; thiazolidinedione treatment reverses these defects.
Bandyopadhyay GK; Yu JG; Ofrecio J; Olefsky JM
Diabetes; 2006 Aug; 55(8):2277-85. PubMed ID: 16873691
[TBL] [Abstract][Full Text] [Related]
4. Fatty liver and insulin resistance in obese Zucker rats: no role for mitochondrial dysfunction.
Flamment M; Arvier M; Gallois Y; Simard G; Malthièry Y; Ritz P; Ducluzeau PH
Biochimie; 2008 Sep; 90(9):1407-13. PubMed ID: 18534199
[TBL] [Abstract][Full Text] [Related]
5. Endurance training in obese humans improves glucose tolerance and mitochondrial fatty acid oxidation and alters muscle lipid content.
Bruce CR; Thrush AB; Mertz VA; Bezaire V; Chabowski A; Heigenhauser GJ; Dyck DJ
Am J Physiol Endocrinol Metab; 2006 Jul; 291(1):E99-E107. PubMed ID: 16464906
[TBL] [Abstract][Full Text] [Related]
6. Peroxisomal oxidation of erucic acid suppresses mitochondrial fatty acid oxidation by stimulating malonyl-CoA formation in the rat liver.
Chen X; Shang L; Deng S; Li P; Chen K; Gao T; Zhang X; Chen Z; Zeng J
J Biol Chem; 2020 Jul; 295(30):10168-10179. PubMed ID: 32493774
[TBL] [Abstract][Full Text] [Related]
7. Evidence of a malonyl-CoA-insensitive carnitine palmitoyltransferase I activity in red skeletal muscle.
Kim JY; Koves TR; Yu GS; Gulick T; Cortright RN; Dohm GL; Muoio DM
Am J Physiol Endocrinol Metab; 2002 May; 282(5):E1014-22. PubMed ID: 11934665
[TBL] [Abstract][Full Text] [Related]
8. Influence of the carnitine palmitoyltransferase inhibitor POCA on myocardial performance and metabolism of insulin resistant rats.
Rösen P; Reinauer H
Acta Physiol Hung; 1988; 71(2):271-80. PubMed ID: 3389170
[TBL] [Abstract][Full Text] [Related]
9. Metformin and exercise reduce muscle FAT/CD36 and lipid accumulation and blunt the progression of high-fat diet-induced hyperglycemia.
Smith AC; Mullen KL; Junkin KA; Nickerson J; Chabowski A; Bonen A; Dyck DJ
Am J Physiol Endocrinol Metab; 2007 Jul; 293(1):E172-81. PubMed ID: 17374701
[TBL] [Abstract][Full Text] [Related]
10. Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance.
Koves TR; Ussher JR; Noland RC; Slentz D; Mosedale M; Ilkayeva O; Bain J; Stevens R; Dyck JR; Newgard CB; Lopaschuk GD; Muoio DM
Cell Metab; 2008 Jan; 7(1):45-56. PubMed ID: 18177724
[TBL] [Abstract][Full Text] [Related]
11. In obese rat muscle transport of palmitate is increased and is channeled to triacylglycerol storage despite an increase in mitochondrial palmitate oxidation.
Holloway GP; Benton CR; Mullen KL; Yoshida Y; Snook LA; Han XX; Glatz JF; Luiken JJ; Lally J; Dyck DJ; Bonen A
Am J Physiol Endocrinol Metab; 2009 Apr; 296(4):E738-47. PubMed ID: 19141681
[TBL] [Abstract][Full Text] [Related]
12. Muscle type-specific fatty acid metabolism in insulin resistance: an integrated in vivo study in Zucker diabetic fatty rats.
Beha A; Juretschke HP; Kuhlmann J; Neumann-Haefelin C; Belz U; Gerl M; Kramer W; Roden M; Herling AW
Am J Physiol Endocrinol Metab; 2006 May; 290(5):E989-97. PubMed ID: 16380389
[TBL] [Abstract][Full Text] [Related]
13. Metformin counters the insulin-induced suppression of fatty acid oxidation and stimulation of triacylglycerol storage in rodent skeletal muscle.
Collier CA; Bruce CR; Smith AC; Lopaschuk G; Dyck DJ
Am J Physiol Endocrinol Metab; 2006 Jul; 291(1):E182-9. PubMed ID: 16478780
[TBL] [Abstract][Full Text] [Related]
14. Consequences of mitochondrial injury induced by pharmaceutical fatty acid oxidation inhibitors is characterized in human and rat liver slices.
Vickers AE; Bentley P; Fisher RL
Toxicol In Vitro; 2006 Oct; 20(7):1173-82. PubMed ID: 16545538
[TBL] [Abstract][Full Text] [Related]
15. Skeletal muscle mitochondrial FAT/CD36 content and palmitate oxidation are not decreased in obese women.
Holloway GP; Thrush AB; Heigenhauser GJ; Tandon NN; Dyck DJ; Bonen A; Spriet LL
Am J Physiol Endocrinol Metab; 2007 Jun; 292(6):E1782-9. PubMed ID: 17311893
[TBL] [Abstract][Full Text] [Related]
16. Deleterious action of FA metabolites on ATP synthesis: possible link between lipotoxicity, mitochondrial dysfunction, and insulin resistance.
Abdul-Ghani MA; Muller FL; Liu Y; Chavez AO; Balas B; Zuo P; Chang Z; Tripathy D; Jani R; Molina-Carrion M; Monroy A; Folli F; Van Remmen H; DeFronzo RA
Am J Physiol Endocrinol Metab; 2008 Sep; 295(3):E678-85. PubMed ID: 18593850
[TBL] [Abstract][Full Text] [Related]
17. Concerted action of leptin in regulation of fatty acid oxidation in skeletal muscle and liver.
Wein S; Ukropec J; Gasperíková D; Klimes I; Seböková E
Exp Clin Endocrinol Diabetes; 2007 Apr; 115(4):244-51. PubMed ID: 17479441
[TBL] [Abstract][Full Text] [Related]
18. Effect of dietary lipid level on fatty acid beta-oxidation and lipid composition in various tissues of haddock, Melanogrammus aeglefinus L.
Nanton DA; Lall SP; Ross NW; McNiven MA
Comp Biochem Physiol B Biochem Mol Biol; 2003 May; 135(1):95-108. PubMed ID: 12781977
[TBL] [Abstract][Full Text] [Related]
19. Alteration of 20:5n-3 and 22:6n-3 fat contents and liver peroxisomal activities in fenofibrate-treated rainbow trout.
Du ZY; Demizieux L; Degrace P; Gresti J; Moindrot B; Liu YJ; Tian LX; Cao JM; Clouet P
Lipids; 2004 Sep; 39(9):849-55. PubMed ID: 15669760
[TBL] [Abstract][Full Text] [Related]
20. Alterations in hepatic mitochondrial compartment in a model of obesity and insulin resistance.
Raffaella C; Francesca B; Italia F; Marina P; Giovanna L; Susanna I
Obesity (Silver Spring); 2008 May; 16(5):958-64. PubMed ID: 18277391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
